Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.

American journal of clinical pathology - 2 Nov 2023

Latham Katherine, Dong Fei

Abstract excerpt

OBJECTIVES: This article aims to establish the relationship between pathologic diagnosis and the rate of success in cancer next-generation sequencing testing. METHODS: Clinical next-generation sequencing results performed for solid tumors were reviewed. The rate of success was analyzed in the context of tumor type and accompanying variables. RESULTS: Out of 683 total specimens, 533 (78.0%) underwent successful...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Melanoma

Share to Mutation

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 37543867
DOI: 10.1093/ajcp/aqad092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.PMID 37543867Read ↗

Challenges to the effectiveness of next-generation sequencing in formalin-fixed paraffin-embedded tumor samples for non-small cell lung cancer.Semantic proximity Read ↗

Impact of DNA integrity on the success rate of tissue‐based next‐generation sequencing: Lessons from nationwide cancer genome screening project SCRUM‐Japan GI‐SCREENSemantic proximity Read ↗

Impact of Pre-analytical Factors on the Success of Comprehensive Genomic Profiling in Gastrointestinal Tract CancersSemantic proximity Read ↗

Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.Semantic proximity Read ↗

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.Semantic proximity Read ↗

Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.Semantic proximity Read ↗

Pearls and Pitfalls of Real-Life Molecular Testing on Fine-Needle Aspiration and Core Biopsy in Pancreatic Adenocarcinoma Practice.Semantic proximity Read ↗

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.Semantic proximity Read ↗

Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility.Semantic proximity Read ↗

Liquid Biopsy-Based Accurate Diagnosis and Genomic Profiling of Hard-to-Biopsy Tumors via Parallel Single-Cell Genomic Sequencing of Exfoliated Tumor Cells.Semantic proximity Read ↗

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.Semantic proximity Read ↗

Prospective multicenter validation of a next-generation sequencing panel using cytology specimens for lung cancer: cPANELSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.